138 related articles for article (PubMed ID: 15233206)
1. The metabolic complications of acromegaly.
Angeletti G
J Endocrinol Invest; 2003; 26(8 Suppl):18-9. PubMed ID: 15233206
[No Abstract] [Full Text] [Related]
2. Acromegaly: effects on bone metabolism and mass.
Bogazzi F; Cosci C; Sardella C; Martino E; Gasperi M
J Endocrinol Invest; 2005; 28(10 Suppl):33-5. PubMed ID: 16550720
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between bone metabolism and lipid/carbohydrate metabolism].
Mizuno Y
Clin Calcium; 2008 May; 18(5):587. PubMed ID: 18581643
[No Abstract] [Full Text] [Related]
4. [Various factors related to carbohydrate metabolism. Growth hormone].
Saito S; Bando H
Nihon Rinsho; 1989 Nov; 47(11):2436-43. PubMed ID: 2601054
[No Abstract] [Full Text] [Related]
5. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
6. Metabolic aspects of acromegaly and its treatment.
Quabbe HJ; Plöckinger U
Metabolism; 1996 Aug; 45(8 Suppl 1):61-2. PubMed ID: 8769384
[TBL] [Abstract][Full Text] [Related]
7. The vascular complications of acromegaly.
Bondanelli M; Zatelli MC; Ambrosio MR; degli Uberti EC
J Endocrinol Invest; 2003; 26(8 Suppl):28-31. PubMed ID: 15233208
[No Abstract] [Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal lipid metabolism in acromegaly].
Inoue T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():162-6. PubMed ID: 11347050
[No Abstract] [Full Text] [Related]
10. Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery.
Höybye C; Chandramouli V; Efendic S; Hulting AL; Landau BR; Schumann WC; Wajngot A
Horm Metab Res; 2008 Jul; 40(7):498-501. PubMed ID: 18393170
[TBL] [Abstract][Full Text] [Related]
11. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
[TBL] [Abstract][Full Text] [Related]
12. Analogue analysis of oral glucose tolerance test and insulin secretion in acromegaly.
Scandellari C; Casara D; Zaccaria M; Sirotich G; Zago E; Sicolo N; Federspil G
Acta Diabetol Lat; 1974; 11(1):61-70. PubMed ID: 4440406
[No Abstract] [Full Text] [Related]
13. The nature of the metabolic bone disorder in acromegaly.
Riggs BL; Randall RV; Wahner HW; Jowsey J; Kelly PJ; Singh M
J Lab Clin Med; 1971 Nov; 78(5):822-3. PubMed ID: 5128866
[No Abstract] [Full Text] [Related]
14. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
15. The metabolic role of growth hormone in humans with particular reference to fasting.
Nørrelund H
Growth Horm IGF Res; 2005 Apr; 15(2):95-122. PubMed ID: 15809014
[No Abstract] [Full Text] [Related]
16. [Activity test in acromegaly].
Annee Endocrinol; 1968; 20():66-70. PubMed ID: 5744050
[No Abstract] [Full Text] [Related]
17. [Serum adiponectin levels in patients with acromegaly].
Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
[TBL] [Abstract][Full Text] [Related]
18. Metabolic consequences of GH deficiency.
Jørgensen JO; Vestergaard E; Gormsen L; Jessen N; Nørrelund H; Christiansen JS; Møller N
J Endocrinol Invest; 2005; 28(5 Suppl):47-51. PubMed ID: 16114276
[TBL] [Abstract][Full Text] [Related]
19. [Disturbances of lipid and lipoprotein metabolism in hypeprolactinemia and acromegaly].
Medić-Stojanoska M; Pletikosić I
Med Pregl; 2009; 62 Suppl 3():91-4. PubMed ID: 19702124
[TBL] [Abstract][Full Text] [Related]
20. A METABOLIC REGULATING DEVICE BASED ON THE ACTIONS OF HUMAN GROWTH HORMONE AND OF INSULIN, SINGLY AND TOGETHER, ON THE HUMAN FOREARM.
RABINOWITZ D; ZIERLER KL
Nature; 1963 Aug; 199():913-5. PubMed ID: 14079908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
